Abate A, Bouyssou I, Mabilotte S, Doderer-Lang C, Dembele L, Menard D, Golassa L. Vivax malaria in Duffy-negative patients shows invariably low asexual parasitaemia: implication towards malaria control in Ethiopia. Malar J. 2022;21:1–10.
Article
Google Scholar
Abkallo HM, Tangena J-A, Tang J, Kobayashi N, Inoue M, Zoungrana A, Colegrave N, Culleton R. Within-host competition does not select for virulence in malaria parasites; studies with Plasmodium yoelii. PLoS Pathog. 2015;11:e1004628.
Article
Google Scholar
Abreha T, Hwang J, Thriemer K, Tadesse Y, Girma S, Melaku Z, Assef A, Kassa M, Chatfield MD, Landman KZ. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial. PLoS Med. 2017;14:e1002299.
Article
Google Scholar
Acharya P, Pallavi R, Chandran S, Dandavate V, Sayeed SK, Rochani A, Acharya J, Middha S, Kochar S, Kochar D. Clinical proteomics of the neglected human malarial parasite Plasmodium vivax. PLoS One. 2011;6:e26623.
Article
CAS
Google Scholar
Adams JH, Mueller I. The biology of Plasmodium vivax. Cold Spring Harb Perspect Med. 2017;7(9):a025585.
Article
Google Scholar
Adapa SR, Taylor RA, Wang C, Thomson-Luque R, Johnson LR, Jiang RHY. Plasmodium vivax readiness to transmit: implication for malaria eradication. BMC Syst Biol. 2019;13:5.
Article
Google Scholar
Aggarwal S, Peng WK, Srivastava S. Multi-omics advancements towards Plasmodium vivax malaria diagnosis. Diagnostics (Basel). 2021;11(12):2222.
Article
CAS
Google Scholar
Ahmad SS, Rahi M, Sharma A. Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India? BMJ Glob Health. 2021;6:e004558.
Article
Google Scholar
Almeida AC, Kuehn A, Castro AJ, Vitor-Silva S, Figueiredo EF, Brasil LW, Brito MA, Sampaio VS, Bassat Q, Felger I. High proportions of asymptomatic and submicroscopic Plasmodium vivax infections in a peri-urban area of low transmission in the Brazilian Amazon. Parasit Vectors. 2018;11:1–13.
Article
Google Scholar
Almeida GG, Costa PAC, Araujo MdS, Gomes GR, Carvalho AF, Figueiredo MM, Pereira DB, Tada MS, Medeiros JF, Soares IdS. Asymptomatic Plasmodium vivax malaria in the Brazilian Amazon: Submicroscopic parasitemic blood infects Nyssorhynchus darlingi. PLoS Neglected Trop Dis. 2021;15:e0009077.
Article
CAS
Google Scholar
Angrisano F, Robinson LJ. Plasmodium vivax–How hidden reservoirs hinder global malaria elimination. Parasitol Int. 2022;87:102526.
Article
Google Scholar
Arévalo-Pinzón G, Bermúdez M, Hernández D, Curtidor H, Patarroyo MA. Plasmodium vivax ligand-receptor interaction: PvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes. Sci Rep. 2017;7:1–13.
Article
Google Scholar
Arnott A, Mueller I, Ramsland PA, Siba PM, Reeder JC, Barry AE. Global population structure of the genes encoding the malaria vaccine candidate, Plasmodium vivax apical membrane antigen 1 (Pv AMA1). PLoS Negl Trop Dis. 2013;7:e2506.
Article
Google Scholar
Arora N, Anbalagan LC, Pannu AK. Towards eradication of malaria: is the WHO’s RTS, S/AS01 vaccination effective enough? Risk Manag Healthcare Policy. 2021;14:1033.
Article
Google Scholar
Asih PB, Syafruddin D, Baird JK. Challenges in the control and elimination of Plasmodium vivax malaria. In: Towards malaria elimination-A leap forward. IntechOpen; 2018.
Google Scholar
Assemie A. Malaria prevalence and distribution of plasmodium species in Southern Region of Ethiopia. J Parasitol Res. 2022;2022:5665660.
Article
Google Scholar
Auburn S, Cheng Q, Marfurt J, Price RN. The changing epidemiology of Plasmodium vivax: insights from conventional and novel surveillance tools. PLoS Med. 2021;18:e1003560.
Article
Google Scholar
Auburn S, Getachew S, Pearson RD, Amato R, Miotto O, Trimarsanto H, Zhu SJ, Rumaseb A, Marfurt J, Noviyanti R, et al. Genomic analysis of Plasmodium vivax in Southern Ethiopia reveals selective pressures in multiple parasite mechanisms. J Infect Dis. 2019;220:1738–49.
Article
CAS
Google Scholar
Badmos AO, Alaran AJ, Adebisi YA, Bouaddi O, Onibon Z, Dada A, Lin X, Lucero-Prisno DE. What sub-Saharan African countries can learn from malaria elimination in China. Trop Med Health. 2021;49:86.
Article
Google Scholar
Baird JK. 8-Aminoquinoline therapy for latent malaria. Clin Microbiol Rev. 2019 Jul 31;32(4):e00011–19. https://doi.org/10.1128/CMR.00011-19. PMID: 31366609; PMCID: PMC6750137.
Baird, J.K. (2022). African Plasmodium vivax malaria improbably rare or benign. Trends in Parasitology.
Baird JK, Valecha N, Duparc S, White NJ, Price RN. Diagnosis and treatment of Plasmodium vivax malaria. Am J Trop Med Hyg. 2016;95:35–51.
Article
CAS
Google Scholar
Bantuchai S, Imad H, Nguitragool W. Plasmodium vivax gametocytes and transmission. Parasitol Int. 2022;87:102497.
Article
CAS
Google Scholar
Barber BE, Rajahram GS, Grigg MJ, William T, Anstey NM. World Malaria Report: time to acknowledge Plasmodium knowlesi malaria. Malar J. 2017;6:1–3.
Bassat Q, Velarde M, Mueller I, Lin J, Leslie T, Wongsrichanalai C, Baird JK. Key knowledge gaps for Plasmodium vivax control and elimination. Am J Trop Med Hyg. 2016;95:62.
Article
Google Scholar
Basso LG, Rodrigues RZ, Naal RM, Costa-Filho AJ. Effects of the antimalarial drug primaquine on the dynamic structure of lipid model membranes. Biochim Biophys Acta. 2011;1808:55–64.
Article
CAS
Google Scholar
Battle KE, Baird JK. The global burden of Plasmodium vivax malaria is obscure and insidious. PLoS Med. 2021;18:e1003799.
Article
CAS
Google Scholar
Blanford JI, Blanford S, Crane RG, Mann ME, Paaijmans KP, Schreiber KV, Thomas MB. Implications of temperature variation for malaria parasite development across Africa. Sci Rep. 2013;3:1–11.
Article
Google Scholar
Edith Christiane B, Sodiomon Bienvenu S. Inherited disorders of hemoglobin and Plasmodium falciparum malaria. In: Osaro E, Anjana M, editors. Human blood group systems and haemoglobinopathies. Rijeka: IntechOpen: 2020. p. Ch. 1.
Bourgard C, Albrecht L, Kayano A, Sunnerhagen P, Costa FTM. Plasmodium vivax biology: insights provided by genomics, transcriptomics and proteomics. Front Cell Infect Microbiol. 2018;8:34.
Article
Google Scholar
Braga CB, Martins AC, Cayotopa AD, Klein WW, Schlosser AR, da Silva AF, de Souza MN, Andrade BW, Filgueira-Júnior JA, Pinto Wde J, et al. Side effects of chloroquine and primaquine and symptom reduction in malaria endemic area (Mâncio Lima, Acre, Brazil). Interdiscip Perspect Infect Dis. 2015;2015:346853.
Article
Google Scholar
Briquet S, Marinach C, Silvie O, Vaquero C. Preparing for transmission: gene regulation in plasmodium sporozoites. Front Cell Infect Microbiol. 2020;10:618430.
Article
CAS
Google Scholar
Bykersma A. The new zoonotic malaria: Plasmodium cynomolgi. Trop Med Infect Dis. 2021;6:46.
Article
Google Scholar
Bylicka-Szczepanowska E, Korzeniewski K. Asymptomatic malaria infections in the time of COVID-19 Pandemic: experience from the Central African Republic. Int J Environ Res Public Health. 2022;19(6):3544.
Article
CAS
Google Scholar
Camarda G, Jirawatcharadech P, Priestley RS, Saif A, March S, Wong MH, Leung S, Miller AB, Baker DA, Alano P. Antimalarial activity of primaquine operates via a two-step biochemical relay. Nat Commun. 2019;10:1–9.
Article
CAS
Google Scholar
Camargo-Ayala PA, Garzón-Ospina D, Moreno-Pérez DA, Ricaurte-Contreras LA, Noya O, Patarroyo MA. On the evolution and function of Plasmodium vivax reticulocyte binding surface antigen (pvrbsa). Front Genet. 2018;9:372.
Article
Google Scholar
Capela R, Moreira R, Lopes F. An overview of drug resistance in protozoal diseases. Int J Mol Sci. 2019;20:5748.
Article
CAS
Google Scholar
Caputo A, Garavelli PL. Climate, environment and transmission of malaria. Infez Med. 2016;2:93–104.
Google Scholar
Carvalho BO, Lopes SC, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, Mamoni R, Leite JA, Rodrigues MM, Soares IS. On the cytoadhesion of Plasmodium vivax–infected erythrocytes. J Infect Dis. 2010;202:638–47.
Article
Google Scholar
Chan LJ, Dietrich MH, Nguitragool W, Tham WH. Plasmodium vivax Reticulocyte Binding Proteins for invasion into reticulocytes. Cell Microbiol. 2020;22:e13110.
Article
CAS
Google Scholar
Chu CS, White NJ. The prevention and treatment of Plasmodium vivax malaria. PLoS Med. 2021;18:e1003561.
Article
CAS
Google Scholar
Clark MA, Kanjee U, Rangel GW, Chery L, Mascarenhas A, Gomes E, Rathod PK, Brugnara C, Ferreira MU, Duraisingh MT. Plasmodium vivax infection compromises reticulocyte stability. Nat Commun. 2021;12:1629.
Article
CAS
Google Scholar
Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, Añez A, Anstey NM, Awab GR, Baird JK. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis. Lancet Infect Dis. 2018;18:1025–34.
Article
CAS
Google Scholar
Conn JE, Grillet, ME, Correa M, Sallum MAM. (2018). Malaria transmission in South America—present status and prospects for elimination. Towards malaria elimination—a leap forward London: InTech, 281–313.
Corder RM, de Lima AC, Khoury DS, Docken SS, Davenport MP, Ferreira MU. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: an observational and modeling study in Brazil. PLoS Negl Trop Dis. 2020;14:e0008526.
Article
Google Scholar
Cui L, et al. Elimination of Plasmodium vivax malaria: problems and solutions. In: Rodriguez-Morales AJ, editor. Current topics and emerging issues in malaria elimination. London: IntechOpen; 2021. https://doi.org/10.5772/intechopen.96604.
D’Souza J, Nderitu D. Ethical considerations for introducing RTS, S/AS01 in countries with moderate to high Plasmodium falciparum malaria transmission. Lancet Glob Health. 2021;9:e1642–3.
Article
Google Scholar
Daniels RF, Rice BL, Daniels NM, Volkman SK, Hartl DL. The utility of genomic data for Plasmodium vivax population surveillance. Pathogens Global Health. 2015;109:153–61.
Article
Google Scholar
de Jong RM, Tebeje SK, Meerstein-Kessel L, Tadesse FG, Jore MM, Stone W, Bousema T. Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites. Immunol Rev. 2020;293:190–215.
Article
Google Scholar
de Pina-Costa A, Silvino ACR, Dos Santos EM, Pedro RS, Moreira J, Umana GL, da Silva ADT, da Rosa Santos OHL, de Deus Henriques KM, Daniel-Ribeiro CT. Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases. Malar J. 2021;20:1–6.
Google Scholar
De SL, Ntumngia FB, Nicholas J, Adams JH. Progress towards the development of a Plasmodium vivax vaccine. Expert Rev Vaccines. 2021;20:97–112.
Article
CAS
Google Scholar
Devine A, Parmiter M, Chu CS, Bancone G, Nosten F, Price RN, Lubell Y, Yeung S. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: a cost-effectiveness analysis. PLoS Negl Trop Dis. 2017;11:e0005602.
Article
Google Scholar
Diez Benavente E, Ward Z, Chan W, Mohareb FR, Sutherland CJ, Roper C, Campino S, Clark TG. Genomic variation in Plasmodium vivax malaria reveals regions under selective pressure. PLoS One. 2017;12:e0177134.
Article
Google Scholar
Ding XC, Ade MP, Baird JK, Cheng Q, Cunningham J, Dhorda M, Drakeley C, Felger I, Gamboa D, Harbers M. Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: target product profiles. PLoS Negl Trop Dis. 2017;11:e0005516.
Article
Google Scholar
Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, Carter N, Cheng Q, Culpepper J, Eziefula C, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391.
Article
Google Scholar
Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN. Artemisinin combination therapy for vivax malaria. Lancet Infect Dis. 2010;10:405–16.
Article
CAS
Google Scholar
Duah NO, Matrevi SA, Quashie NB, Abuaku B, Koram KA. Genetic diversity of Plasmodium falciparum isolates from uncomplicated malaria cases in Ghana over a decade. Parasit Vectors. 2016;9:416.
Article
Google Scholar
Duffy PE, Acharya P, Oleinikov AV. (2014). Journal: Encyclopedia of Malaria, 2014, 1–13. Journal: Encyclopedia of Malaria, 1–13.
Durnez L, Coosemans M. Residual transmission of malaria: an old issue for new approaches. In: Anopheles mosquitoes: new insights into malaria vectors/Manguin, Sylvie; 2013. p. 671–704.
Engel N, Ghergu C, Matin MA, Kibria MG, Thriemer K, Price RN, Ding XC, Howes RE, Ley B, Incardona S. Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh. Malar J. 2021;20:1–12.
Article
Google Scholar
Escalante AA, Cepeda AS, Pacheco MA. Why Plasmodium vivax and Plasmodium falciparum are so different? A tale of two clades and their species diversities. Malar J. 2022;21:1–19.
Article
Google Scholar
Fernandez-Becerra C, Bernabeu M, Castellanos A, Correa BR, Obadia T, Ramirez M, Rui E, Hentzschel F, López-Montañés M, Ayllon-Hermida A. Plasmodium vivax spleen-dependent genes encode antigens associated with cytoadhesion and clinical protection. Proc Natl Acad Sci. 2020;117:13056–65.
Article
CAS
Google Scholar
Ferreira MU, Corder RM, Johansen IC, Kattenberg JH, Moreno M, Rosas-Aguirre A, Ladeia-Andrade S, Conn JE, Llanos-Cuentas A, Gamboa D. Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys. Lancet Regional Health-Americas. 2022;9:100169.
Article
Google Scholar
Ferreira MU, de Oliveira TC. Challenges for Plasmodium vivax malaria elimination in the genomics era. Pathogens Glob Health. 2015;109:89–90.
Article
Google Scholar
Ferreira MU, Gamboa D, Torres K, Rodriguez-Ferrucci H, Soto-Calle VE, Pardo K, Fontoura PS, Tomko SS, Gazzinelli RT, Conn JE. Evidence-based malaria control and elimination in the Amazon: input from the International Center of excellence in malaria research network in Peru and Brazil. Am J Trop Med Hyg. 2022;107:160–7.
Article
CAS
Google Scholar
Ferreira MU, Nobrega de Sousa T, Rangel GW, Johansen IC, Corder RM, Ladeia-Andrade S, Gil JP. Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions. Int J Parasitol Drugs Drug Resist. 2021;15:9–24.
Article
CAS
Google Scholar
File T, Dinka H, Golassa L. A retrospective analysis on the transmission of Plasmodium falciparum and Plasmodium vivax: the case of Adama City, East Shoa Zone, Oromia. Ethiopia Malaria Journal. 2019;18:193.
Article
Google Scholar
Finney M, McKenzie BA, Rabaovola B, Sutcliffe A, Dotson E, Zohdy S. Widespread zoophagy and detection of Plasmodium spp. in Anopheles mosquitoes in southeastern Madagascar. Malar J. 2021;20:1–12.
Article
Google Scholar
Fischer L, Gültekin N, Kaelin MB, Fehr J, Schlagenhauf P. Rising temperature and its impact on receptivity to malaria transmission in Europe: a systematic review. Travel Med Infect Dis. 2020;36:101815.
Article
Google Scholar
Fontoura PS, Finco BF, Lima NF, de Carvalho Jr JF, Vinetz JM, Castro MC, Ferreira MU. Reactive case detection for Plasmodium vivax malaria elimination in rural Amazonia. PLoS Negl Trop Dis. 2016;10:e0005221.
Article
Google Scholar
Gari T, Solomon T, Lindtjørn B. Older children are at increased risk of Plasmodium vivax in south-central Ethiopia: a cohort study. Malar J. 2021;20:251.
Article
Google Scholar
Garzón-Ospina D, Buitrago SP, Ramos AE, Patarroyo MA. Identifying potential Plasmodium vivax sporozoite stage vaccine candidates: an analysis of genetic diversity and natural selection. Front Genet. 2018;9:10.
Article
Google Scholar
Gilder ME, Hanpithakphong W, Hoglund RM, Tarning J, Win HH, Hilda N, Chu CS, Bancone G, Carrara VI, Singhasivanon P, et al. Primaquine pharmacokinetics in lactating women and breastfed infant exposures. Clin Infect Dis. 2018;67:1000–7.
Article
CAS
Google Scholar
Giovanella F, Ferreira GK, PRÁ SDD, Carvalho-Silva M, Gomes LM, Scaini G, Goncalves RC, Michels M, Galant LS, Longaretti LM. Effects of primaquine and chloroquine on oxidative stress parameters in rats. An Acad Bras Cienc. 2015;87:1487–96.
Golassa L, Amenga-Etego L, Lo E, Amambua-Ngwa A. The biology of unconventional invasion of Duffy-negative reticulocytes by Plasmodium vivax and its implication in malaria epidemiology and public health. Malar J. 2020;19:1–10.
Article
Google Scholar
Gopi G, Behera SM, Behera P. Tafenoquine: a breakthrough drug for radical cure and elimination of Malaria. Exploratory Res Hypothesis Med. 2019;4:29–34.
Google Scholar
Grillet ME, Moreno JE, Hernández-Villena JV, Vincenti-González MF, Noya O, Tami A, Paniz-Mondolfi A, Llewellyn M, Lowe R, Escalante AA. Malaria in Southern Venezuela: the hottest hotspot in Latin America. PLoS Negl Trop Dis. 2021;15:e0008211.
Article
Google Scholar
Gualdrón-López M, Flannery EL, Kangwanrangsan N, Chuenchob V, Fernandez-Orth D, Segui-Barber J, Royo F, Falcón-Pérez JM, Fernandez-Becerra C, Lacerda MV. Characterization of Plasmodium vivax proteins in plasma-derived exosomes from malaria-infected liver-chimeric humanized mice. Front Microbiol. 2018;9:1271.
Article
Google Scholar
Gunalan K, Niangaly A, Thera MA, Doumbo OK, Miller LH. Plasmodium vivax infections of Duffy-negative erythrocytes: historically undetected or a recent adaptation? Trends Parasitol. 2018;34:420–9.
Article
Google Scholar
Gupta S, Singh S, Popovici J, Roesch C, Shakri AR, Guillotte-Blisnick M, Huon C, Menard D, Chitnis CE. Targeting a reticulocyte binding protein and Duffy binding protein to inhibit reticulocyte invasion by Plasmodium vivax. Sci Rep. 2018;8:10511.
Article
Google Scholar
Gural N, Mancio-Silva L, Miller AB, Galstian A, Butty VL, Levine SS, Patrapuvich R, Desai SP, Mikolajczak SA, Kappe SH. In vitro culture, drug sensitivity, and transcriptome of Plasmodium vivax hypnozoites. Cell Host Microbe. 2018;23(395–406):e394.
Google Scholar
Haileselassie W, Parker DM, Taye B, David RE, Zemene E, Lee M-C, Zhong D, Zhou G, Alemu T, Tadele G. Burden of malaria, impact of interventions and climate variability in Western Ethiopia: an area with large irrigation based farming. BMC Public Health. 2022;22:1–11.
Article
Google Scholar
Haiyambo DH, Aleksenko L, Mumbengegwi D, Bock R, Uusiku P, Malleret B, Rénia L, Quaye IK. Children with Plasmodium vivax infection previously observed in Namibia, were Duffy negative and carried a c. 136G> A mutation. BMC Infect Dis. 2021;21:1–6.
Article
Google Scholar
Hammer H, Schmidt F, Marx-Stoelting P, Pötz O, Braeuning A. Cross-species analysis of hepatic cytochrome P450 and transport protein expression. Arch Toxicol. 2021;95:117–33.
Article
CAS
Google Scholar
Hanboonkunupakarn B, White NJ. Advances and roadblocks in the treatment of malaria. Br J Clin Pharmacol. 2022;88:374–82.
Article
Google Scholar
He W-Q, Karl S, White MT, Nguitragool W, Monteiro W, Kuehn A, Gruszczyk J, França CT, Sattabongkot J, Lacerda MV. Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against Plasmodium vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand. PLoS Negl Trop Dis. 2019;13:e0007596.
Article
Google Scholar
Heidari A, Keshavarz H. The drug resistance of Plasmodium falciparum and Plasmodium vivax in Iran: a review article. Iran J Parasitol. 2021;16:173.
Google Scholar
Hemingway J, Shretta R, Wells TN, Bell D, Djimdé AA, Achee N, Qi G. Tools and strategies for malaria control and elimination: what do we need to achieve a grand convergence in malaria? PLoS Biol. 2016;14:e1002380.
Article
Google Scholar
Hounkpatin AB, Kreidenweiss A, Held J. Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data. Infect Drug Resist. 2019;12:553–70.
Article
CAS
Google Scholar
Howes RE, Battle KE, Mendis KN, Smith DL, Cibulskis RE, Baird JK, Hay SI. Global Epidemiology of Plasmodium vivax. Am J Trop Med Hyg. 2016;95:15–34.
Article
Google Scholar
Huang F, Li S, Tian P, Pu LJS, Cui Y, Liu H, Yang L, Bi DY. Genetic polymorphisms in genes associated with drug resistance in Plasmodium vivax parasites from northeastern Myanmar. Malar J. 2022;21:66.
Article
CAS
Google Scholar
Huber JH, Koepfli C, España G, Nekkab N, White MT, Alex Perkins T. How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites. Malar J. 2021;20:1–15.
Article
Google Scholar
Ippolito MM, Moser KA, Kabuya J-BB, Cunningham C, Juliano JJ. Antimalarial drug resistance and implications for the WHO global technical strategy. Curr Epidemiol Rep. 2021;8:46–62.
Article
Google Scholar
Jennison C, Arnott A, Tessier N, Tavul L, Koepfli C, Felger I, Siba PM, Reeder JC, Bahlo M, Mueller I. Plasmodium vivax populations are more genetically diverse and less structured than sympatric Plasmodium falciparum populations. PLoS Negl Trop Dis. 2015;9:e0003634.
Article
Google Scholar
Kanjee U, Rangel GW, Clark MA, Duraisingh MT. Molecular and cellular interactions defining the tropism of Plasmodium vivax for reticulocytes. Curr Opin Microbiol. 2018;46:109–15.
Article
CAS
Google Scholar
Kepple D, Ford A, Little E, Kolesar G, Abagero BR, Blackwell AN, De Silva Indrasekara S, Yewhalaw D, Lo E. From Genes to Biomarkers: Understanding the biology of malaria gametocytes and their detection. In: Çalışkan M, editor. Genetic polymorphisms - new insights [Internet]. London: IntechOpen; 2021 [cited 2022 Nov 30]. Available from: https://www.intechopen.com/chapters/78331. https://doi.org/10.5772/intechopen.99364.
Kepple D, Pestana K, Tomida J, Abebe A, Golassa L, Lo E. Alternative invasion mechanisms and host immune response to Plasmodium vivax malaria: trends and future directions. Microorganisms. 2021;9:15.
Article
CAS
Google Scholar
Khammanee T, Sawangjaroen N, Buncherd H, Tun AW, Thanapongpichat S. Prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency among malaria patients in Southern Thailand: 8 years retrospective study. Korean J Parasitol. 2022;60:15.
Article
Google Scholar
Kitchakarn S, Lek D, Thol S, Hok C, Saejeng A, Huy R, Chinanonwait N, Thimasarn K, Wongsrichanalai C. Implementation of G6PD testing and primaquine for Plasmodium vivax radical cure: operational perspectives from Thailand and Cambodia. WHO South East Asia J Public Health. 2017;6:60–8.
Article
Google Scholar
Koepfli C, Nguitragool W, de Almeida ACG, Kuehn A, Waltmann A, Kattenberg E, Ome-Kaius M, Rarau P, Obadia T, Kazura J. Identification of the asymptomatic gametocyte reservoir under different transmission intensities. Plasmodium falciparum and Plasmodium vivaxoS Negl Trop Dis. 2021;15:e0009672.
Article
Google Scholar
Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, Yilma D, Batista Pereira D, Espino FEJ, Mia RZ, et al. Single-dose tafenoquine to prevent relapse of Plasmodium vivax Malaria. N Engl J Med. 2019;380:215–28.
Article
CAS
Google Scholar
Laporta GZ, Ilacqua RC, Bergo ES, Chaves LS, Rodovalho SR, Moresco GG, Figueira EA, Massad E, de Oliveira TM, Bickersmith SA. Malaria transmission in landscapes with varying deforestation levels and timelines in the Amazon: a longitudinal spatiotemporal study. Sci Rep. 2021;11:1–14.
Article
Google Scholar
Larson B. Origin of two most virulent agents of human malaria: Plasmodium falciparum and Plasmodium vivax. In: Fyson HK, editor. Malaria. Rijeka: IntechOpen; 2019. p. Ch. 1.
Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther. 2013;11:623–39.
Article
CAS
Google Scholar
Lee W-C, Cheong FW, Amir A, Lai MY, Tan JH, Phang WK, Shahari S, Lau Y-L. Plasmodium knowlesi: the game changer for malaria eradication. Malar J. 2022;21:1–24.
Article
Google Scholar
Lee W-C, Russell B, Rénia L. Sticking for a cause: the falciparum malaria parasites cytoadherence paradigm. Front Immunol. 2019;10:1444.
Article
CAS
Google Scholar
Lempang MEP, Dewayanti FK, Syahrani L, Permana DH, Malaka R, Asih PBS, Syafruddin D. Primate malaria: an emerging challenge of zoonotic malaria in Indonesia. One Health (Amsterdam, Netherlands). 2022;14:100389.
Google Scholar
Leong YW, Lee EQH, Rénia L, Malleret B. Rodent malaria erythrocyte preference assessment by an Ex Vivo Tropism Assay. Front Cell Infect Microbiol. 2021;11:680136.
Article
CAS
Google Scholar
Ley B, Thriemer K, Jaswal J, Poirot E, Alam MS, Phru CS, Khan WA, Dysoley L, Qi G, Kheong CC, et al. Barriers to routine G6PD testing prior to treatment with Primaquine. Malar J. 2017;16:329.
Article
Google Scholar
Lingani M, Zango SH, Valéa I, Sanou M, Ouoba S, Samadoulougou S, Robert A, Tinto H, Dramaix M, Donnen P. Prevalence and risk factors of malaria among first antenatal care attendees in rural Burkina Faso. Trop Med Health. 2022;50:1–8.
Article
Google Scholar
Llanos-Cuentas A, Manrrique P, Rosas-Aguirre A, Herrera S, Hsiang MS. Tafenoquine for the treatment of Plasmodium vivax malaria. Expert Opin Pharmacother. 2022;23:759–68.
Article
CAS
Google Scholar
Lo E, Russo G, Pestana K, Kepple D, Abagero BR, Dongho GBD, Gunalan K, Miller LH, Hamid MMA, Yewhalaw D. Contrasting epidemiology and genetic variation of Plasmodium vivax infecting Duffy-negative individuals across Africa. Int J Infect Dis. 2021;108:63–71.
Article
CAS
Google Scholar
Lo E, Zhong D, Raya B, Pestana K, Koepfli C, Lee M-C, Yewhalaw D, Yan G. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia. Malar J. 2019;18:1–10.
Article
CAS
Google Scholar
Lo E, Zhou G, Oo W, Afrane Y, Githeko A, Yan G. Low parasitemia in submicroscopic infections significantly impacts malaria diagnostic sensitivity in the highlands of Western Kenya. PLoS One. 2015;10:e0121763.
Article
Google Scholar
Loeffel M, Ross A. The relative impact of interventions on sympatric Plasmodium vivax and Plasmodium falciparum malaria: A systematic review. PLoS Negl Trop Dis. 2022;16:e0010541.
Article
Google Scholar
Luo Z, Sullivan SA, Carlton JM. The biology of Plasmodium vivax explored through genomics. Ann N Y Acad Sci. 2015;1342:53–61.
Article
CAS
Google Scholar
Lyon B, Dinku T, Raman A, Thomson MC. Temperature suitability for malaria climbing the Ethiopian Highlands. Environ Res Lett. 2017;12:064015.
Article
Google Scholar
Mac Donald-Ottevanger MS, Adhin MR, Jitan JK, Bretas G, Vreden SG. Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname. Infect Drug Resist. 2018;11:3–8.
Article
CAS
Google Scholar
Magliocco G, Desmeules J, Matthey A, Quirós-Guerrero LM, Bararpour N, Joye T, Marcourt L, Queiroz EF, Wolfender JL, Gloor Y. Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity. Br J Pharmacol. 2021;178:4708–25.
Article
CAS
Google Scholar
Malleret B, Li A, Zhang R, Tan KS, Suwanarusk R, Claser C, Cho JS, Koh EGL, Chu CS, Pukrittayakamee S. Plasmodium vivax: restricted tropism and rapid remodeling of CD71-positive reticulocytes. Blood. 2015;125:1314–24.
Article
CAS
Google Scholar
Malvy D, Torrentino-Madamet M, l'Ollivier C, Receveur M-C, Jeddi F, Delhaes L, Piarroux R, Millet P, Pradines B. Plasmodium falciparum recrudescence two years after treatment of an uncomplicated infection without return to an area where malaria is endemic. Antimicrob Agents Chemother. 2018;62:e01892–01817.
Marcsisin SR, Reichard G, Pybus BS. Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: current state of the art. Pharmacol Ther. 2016;161:1–10.
Article
CAS
Google Scholar
Marín-Menéndez A, Bardají A, Martínez-Espinosa FE, Bôtto-Menezes C, Lacerda MV, Ortiz J, Cisteró P, Piqueras M, Felger I, Müeller I. Rosetting in Plasmodium vivax: a cytoadhesion phenotype associated with anaemia. PLoS Negl Trop Dis. 2013;7:e2155.
Article
Google Scholar
Mehlotra RK, Gaedigk A, Howes RE, Rakotomanga TA, Ratsimbasoa AC, Zimmerman PA. CYP2D6 genetic variation and its implication for vivax malaria treatment in Madagascar. Front Pharmacol. 2021;12:654054.
Article
CAS
Google Scholar
Menkin-Smith L, Winders WT. Plasmodium Vivax Malaria. [Updated 2022 Jul 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538333/.
Mikolajczak SA, Vaughan AM, Kangwanrangsan N, Roobsoong W, Fishbaugher M, Yimamnuaychok N, Rezakhani N, Lakshmanan V, Singh N, Kaushansky A. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe. 2015;17:526–35.
Article
CAS
Google Scholar
Milligan R, Daher A, Graves PM. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev. 2019;7:2656.
Google Scholar
Minter M, Nielsen ES, Blyth C, Bertola LD, Kantar MB, Morales HE, Orland C, Segelbacher G, Leigh DM. What is genetic diversity and why does it matter? 2021.
Book
Google Scholar
Mironova V, Shartova N, Beljaev A, Varentsov M, Grishchenko M. Effects of climate change and heterogeneity of local climates on the development of malaria parasite (Plasmodium vivax) in Moscow megacity region. Int J Environ Res Public Health. 2019;16:694.
Article
Google Scholar
Mitali M, Vikash Kumar M, Varsha K, Sushil Kumar K. Molecular approaches for malaria therapy. In: Rajeev KT, editor. Plasmodium species and drug resistance. Rijeka: IntechOpen; 2021. p. Ch. 8.
Monroe A, Williams NA, Ogoma S, Karema C, Okumu F. Reflections on the 2021 World Malaria Report and the future of malaria control. Malar J. 2022;21:154.
Article
CAS
Google Scholar
Muller I, Jex AR, Kappe SH, Mikolajczak SA, Sattabongkot J, Patrapuvich R, Lindner S, Flannery EL, Koepfli C, Ansell B, Lerch A. Transcriptome and histone epigenome of Plasmodium vivax salivary-gland sporozoites point to tight regulatory control and mechanisms for liver-stage differentiation in relapsing malaria. Int J Parasitol. 2019;49(7):501–13.
Article
Google Scholar
Myers-Hansen JL, Abuaku B, Oyebola MK, Mensah BA, Ahorlu C, Wilson MD, Awandare G, Koram KA, Ngwa AA, Ghansah A. Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana. PLoS One. 2020;15:e0233478.
Article
CAS
Google Scholar
Naing C, Htet NH, Aye SN, Aung HH, Tanner M, Whittaker MA. Detection of asymptomatic malaria in Asian countries: a meta-analysis of diagnostic accuracy. Malar J. 2022;21:50.
Article
CAS
Google Scholar
Nascimento JR, Brito-Sousa JD, Almeida ACG, Melo MM, Costa MRF, Barbosa LRA, Ramos RN, Silva-Neto AV, da Silva Balieiro PC, Figueiredo EFG. Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: A region-wide screening study. Lancet Regional Health-Americas. 2022;12:100273.
Article
Google Scholar
Nekkab N, Lana R, Lacerda M, Obadia T, Siqueira A, Monteiro W, Villela D, Mueller I, White M. Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study. PLoS Med. 2021;18:e1003535.
Article
CAS
Google Scholar
Ngotho P, Soares AB, Hentzschel F, Achcar F, Bertuccini L, Marti M. Revisiting gametocyte biology in malaria parasites. FEMS Microbiol Rev. 2019;43:401–14.
Article
CAS
Google Scholar
Nguitragool W, Mueller I, Kumpitak C, Saeseu T, Bantuchai S, Yorsaeng R, Yimsamran S, Maneeboonyang W, Sa-Angchai P, Chaimungkun W. Very high carriage of gametocytes in asymptomatic low-density Plasmodium falciparum and Plasmodium vivax infections in western Thailand. Parasit Vectors. 2017;10:1–9.
Article
Google Scholar
Noisang C, Prosser C, Meyer W, Chemoh W, Ellis J, Sawangjaroen N, Lee R. Molecular detection of drug resistant malaria in Southern Thailand. Malar J. 2019;18:275.
Article
Google Scholar
Noviyanti R, Carey-Ewend K, Trianty L, Parobek C, Puspitasari AM, Balasubramanian S, Park Z, Hathaway N, Utami RA, Soebianto S. Hypnozoite depletion in successive Plasmodium vivax relapses. PLoS Neglect Trop Dis. 2022;16:e0010648.
Obaldia N 3rd, Meibalan E, Sa JM, Ma S, Clark MA, Mejia P, Moraes Barros RR, Otero W, Ferreira MU, Mitchell JR, Milner DA, Huttenhower C, Wirth DF, Duraisingh MT, Wellems TE, Marti M. Bone marrow is a major parasite reservoir in Plasmodium vivax Infection. mBio. 2018;9(3):e00625–18. https://doi.org/10.1128/mBio.00625-18.
Obaldía N, Barahona I, Lasso J, Avila M, Quijada M, Nuñez M, Marti M. Comparison of PvLAP5 and Pvs25 qRT-PCR assays for the detection of Plasmodium vivax gametocytes in field samples preserved at ambient temperature from remote malaria endemic regions of Panama. PLoS Negl Trop Dis. 2022;16:e0010327.
Article
Google Scholar
Oduma CO, Koepfli C. Plasmodium falciparum and Plasmodium vivax Adjust investment in transmission in response to change in transmission intensity: a review of the current state of research. Front Cellular Infect Microbiol. 2021;11:1237.
Article
Google Scholar
Oladipo HJ, Tajudeen YA, Oladunjoye IO, Yusuff SI, Yusuf RO, Oluwaseyi EM, AbdulBasit MO, Adebisi YA, El-Sherbini MS. Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers. Ann Med Surg. 2022;81:104366.
Article
Google Scholar
Olliaro PL, Barnwell JW, Barry A, Mendis K, Mueller I, Reeder JC, Shanks GD, Snounou G, Wongsrichanalai C. Implications of Plasmodium vivax biology for control, elimination, and research. Am J Trop Med Hyg. 2016;95:4–14.
Article
CAS
Google Scholar
Ome-Kaius M, Kattenberg JH, Zaloumis S, Siba M, Kiniboro B, Jally S, Razook Z, Mantila D, Sui D, Ginny J. Differential impact of malaria control interventions on Plasmodium falciparum and Plasmodium vivax infections in young Papua New Guinean children. BMC Med. 2019;17:1–13.
Article
Google Scholar
Park JW. Changing Transmission Pattern of Plasmodium vivax malaria in the Republic of Korea: relationship with climate change. Environ Health Toxicol. 2011;26:e2011001. https://doi.org/10.5620/eht.2011.26.e2011001. Epub 2011 Mar 8.
Pasini EM, Kocken CH. Parasite-host interaction and pathophysiology studies of the human relapsing malarias Plasmodium vivax and Plasmodium ovale infections in non-human primates. Front Cell Infect Microbiol. 2021;10:614122.
Article
Google Scholar
Patankar S, Sharma S, Rathod PK, Duraisingh MT. Malaria in India: The need for new targets for diagnosis and detection of Plasmodium vivax. Proteomics Clin Appl. 2018;12:e1700024.
Article
Google Scholar
Paton DG, Childs LM, Itoe MA, Holmdahl IE, Buckee CO, Catteruccia F. Exposing Anopheles mosquitoes to antimalarials blocks Plasmodium parasite transmission. Nature. 2019;567:239–43.
Article
CAS
Google Scholar
Patouillard E, Griffin J, Bhatt S, Ghani A, Cibulskis R. Global investment targets for malaria control and elimination between 2016 and 2030. BMJ Glob Health. 2017;2:e000176.
Article
Google Scholar
Pett H, Bradley J, Okebe J, Dicko A, Tiono AB, Gonçalves BP, Stone W, Chen I, Lanke K, Neuvonen M. CYP2D6 polymorphisms and the safety and gametocytocidal activity of single-dose primaquine for Plasmodium falciparum. Antimicrob Agents Chemother. 2019;63:e00538-e519.
Article
CAS
Google Scholar
Pham Vinh T. Epidemiology of Plasmodium vivax malaria in Central Vietnam. UCL-Université Catholique de Louvain; 2018.
Phyo AP, Dahal P, Mayxay M, Ashley EA. Clinical impact of vivax malaria: a collection review. PLoS Med. 2022;19:e1003890.
Article
Google Scholar
Popovici J, Roesch C, Rougeron V. The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals. PLoS Pathog. 2020;16:e1008258.
Article
CAS
Google Scholar
Potter BM, Xie LH, Vuong C, Zhang J, Zhang P, Duan D, Luong T-LT, Bandara Herath H, Dhammika Nanayakkara N, Tekwani BL. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics. Antimicrob Agents Chemother. 2015;59:2380–7.
Article
CAS
Google Scholar
Prah JK, Amoah S, Yartey AN, Ampofo-Asiama A, Ameyaw EO. Assessment of malaria diagnostic methods and treatments at a Ghanaian health facility. Pan Afr Med J. 2021;39:251.
Article
Google Scholar
Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the Era of the Shrinking Plasmodium falciparum Map. Trends Parasitol. 2020;36:560–70.
Article
Google Scholar
Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the Era of the Shrinking Plasmodium falciparum Map. Trends Parasitol. 2020;36:560–70.
Article
Google Scholar
Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:982–91.
Article
Google Scholar
Rehn T, Lubiana P, Nguyen THT, Pansegrau E, Schmitt M, Roth LK, Brehmer J, Roeder T, Cadar D, Metwally NG. Ectopic expression of Plasmodium vivax vir Genes in Plasmodium falciparum affects cytoadhesion via increased expression of specific var genes. Microorganisms. 2022;10:1183.
Article
CAS
Google Scholar
Rishikesh K, Saravu K. Primaquine treatment and relapse in Plasmodium vivax malaria. Pathogens Global Health. 2016;110:1–8.
Article
CAS
Google Scholar
Rodrigo C, Rajapakse S, Fernando D. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev. 2020;9:10458.
Google Scholar
Rodríguez JAI, Rodríguez SNI, Olivera MJ. Plasmodium vivax malaria across South America: management guidelines and their quality assessment. Rev Soc Bras Med Trop. 2020;53:e20200179.
Article
Google Scholar
Rosenthal PJ. Malaria in 2022: Challenges and progress. Am J Trop Med Hyg. 2022;106:1565–7.
Article
Google Scholar
Russo G, Faggioni G, Paganotti GM, Djeunang Dongho GB, Pomponi A, De Santis R, Tebano G, Mbida M, Sanou Sobze M, Vullo V. Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals from Dschang, West Cameroon. Malar J. 2017;16:1–9.
Article
Google Scholar
Sato S. Plasmodium—a brief introduction to the parasites causing human malaria and their basic biology. J Physiol Anthropol. 2021;40:1.
Article
Google Scholar
Shaikh MS, Ali B, Janjua M, Akbar A, Haider SA, Moiz B, Raheem A, Baird JK, Beg MA. Plasmodium in the bone marrow: case series from a hospital in Pakistan, 2007–2015. Malar J. 2021;20:1–6.
Article
Google Scholar
Sharma S, Verma R, Yadav B, Kumar A, Rahi M, Sharma A. What India can learn from globally successful malaria elimination programmes. BMJ Glob Health. 2022;7:e008431.
Article
Google Scholar
Soto AM, González-Cerón L, Santillán-Valenzuela F, Parrales ME, Montoya A. Recurrent Plasmodium vivax cases of both short and long latency increased with transmission intensity and were distributed year-round in the most affected municipalities of the RACCN, Nicaragua, 2013–2018. Int J Environ Res Public Health. 2022;19:6195.
Article
Google Scholar
Spring MD, Lon C, Sok S, Sea D, Wojnarski M, Chann S, Kuntawunginn W, Kheang Heng T, Nou S, Arsanok M, et al. Prevalence of CYP2D6 genotypes and predicted phenotypes in a cohort of Cambodians at high risk for infections with Plasmodium vivax. Am J Trop Med Hyg. 2020;103:756–9.
Article
CAS
Google Scholar
Spring MD, Sousa JC, Li Q, Darko CA, Morrison MN, Marcsisin SR, Mills KT, Potter BM, Paolino KM, Twomey PS, et al. Determination of cytochrome P450 isoenzyme 2D6 (CYP2D6) genotypes and pharmacogenomic impact on primaquine metabolism in an active-duty US military population. J Infect Dis. 2019;220:1761–70.
Article
CAS
Google Scholar
Stevens-Hernandez CJ, Flatt JF, Kupzig S, Bruce LJ. Reticulocyte maturation and variant red blood cells. Front Physiol. 2022;13:834463. https://doi.org/10.3389/fphys.2022.834463.
Stewart AGA, Zimmerman PA, McCarthy JS. Genetic Variation of G6PD and CYP2D6: Clinical Implications on the use of primaquine for elimination of Plasmodium vivax. Front Pharmacol. 2021;12:784909.
Article
CAS
Google Scholar
Storm J, Jespersen JS, Seydel KB, Szestak T, Mbewe M, Chisala NV, Phula P, Wang CW, Taylor TE, Moxon CA. Cerebral malaria is associated with differential cytoadherence to brain endothelial cells. EMBO Mol Med. 2019;11:e9164.
Article
Google Scholar
Styka AN, Savitz DA. 2020. Assessment of long-term health effects of antimalarial drugs when used for prophylaxis.
Su X-Z, Zhang C, Joy DA. Host-malaria parasite interactions and impacts on mutual evolution. Front Cell Infect Microbiol. 2020;10:587933.
Article
CAS
Google Scholar
Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Meilia RA, Setiabudy R, Nurleila S, Ekawati LL, Elyazar I. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia. Antimicrob Agents Chemother. 2013;57:1128–35.
Article
CAS
Google Scholar
Taylor C, Crosby I, Yip V, Maguire P, Pirmohamed M, Turner RM. A review of the important role of CYP2D6 in pharmacogenomics. Genes. 2020;11:1295.
Article
CAS
Google Scholar
Taylor AR, Watson JA, Chu CS, Puaprasert K, Duanguppama J, Day NPJ, Nosten F, Neafsey DE, Buckee CO, Imwong M, et al. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically. Nat Commun. 2019;10:5595.
Article
CAS
Google Scholar
Teklehaimanot A, Teklehaimanot H, Girmay A, Woyessa A. Case report: primaquine failure for radical cure of Plasmodium vivax malaria in Gambella, Ethiopia. Am J Trop Med Hyg. 2020;103:415–20.
Article
Google Scholar
Tham W-H, Beeson JG, Rayner JC. Plasmodium vivax vaccine research–we’ve only just begun. Int J Parasitol. 2017;47:111–8.
Article
Google Scholar
Thomas D, Tazerouni H, Sundararaj KGS, Cooper JC. Therapeutic failure of primaquine and need for new medicines in radical cure of Plasmodium vivax. Acta Trop. 2016;160:35–8.
Article
CAS
Google Scholar
Thomson-Luque R, Bautista JM. Home Sweet Home: Plasmodium vivax-infected reticulocytes-the younger the better? Front Cell Infect Microbiol. 2021;11:675156.
Article
CAS
Google Scholar
Thomson-Luque R, Scopel KK. Immature reticulocytes as preferential host cells and the challenges for in vitro culture of Plasmodium vivax. Taylor & Francis; 2015.
Google Scholar
Tiwari M. Glucose 6 phosphatase dehydrogenase (G6PD) and neurodegenerative disorders: mapping diagnostic and therapeutic opportunities. Genes Dis. 2017;4:196–203.
Article
CAS
Google Scholar
Torres K, Ferreira MU, Castro MC, Escalante AA, Conn JE, Villasis E, da Silva Araujo M, Almeida G, Rodrigues PT, Corder RM. Malaria resilience in South America: epidemiology, vector biology, and immunology insights from the Amazonian International Center of excellence in malaria research network in Peru and Brazil. Am J Trop Med Hyg. 2022;107:168–81.
Article
CAS
Google Scholar
Totino PR, Lopes SC. Insights into the cytoadherence phenomenon of Plasmodium vivax: the putative role of phosphatidylserine. Front Immunol. 2017;8:1148.
Article
Google Scholar
Vallejo AF, García J, Amado-Garavito AB, Arévalo-Herrera M, Herrera S. Plasmodium vivax gametocyte infectivity in sub-microscopic infections. Malar J. 2016;15:48.
Article
Google Scholar
Vantaux A, Péneau J, Cooper CA, Kyle DE, Witkowski B, Maher SP. Liver stage fate determination in Plasmodium vivax parasites: characterization of schizont growth and hypnozoite fating from patient isolates. bioRxiv. 2022.06.16.496373. https://doi.org/10.1101/2022.06.16.496373.
Venkatesan P. The future of malaria control in light of RTS. S The Lancet Microbe. 2022;3:e251.
Article
Google Scholar
Venugopal K, Hentzschel F, Valkiūnas G, Marti M. Plasmodium asexual growth and sexual development in the haematopoietic niche of the host. Nat Rev Microbiol. 2020;18:177–89.
Article
CAS
Google Scholar
Verma A, Joshi H, Singh V, Anvikar A, Valecha N. Plasmodium vivax msp-3α polymorphisms: analysis in the Indian subcontinent. Malar J. 2016;15:1–13.
Article
Google Scholar
Viviani R, Messina I, Bosch JE, Dommes L, Paul A, Schneider KL, Scholl C, Stingl JC. Effects of genetic variability of CYP2D6 on neural substrates of sustained attention during on-task activity. Transl Psychiatry. 2020;10:338.
Article
CAS
Google Scholar
Voorberg-van der Wel A, Kocken CHM, Zeeman AM. Modeling Relapsing Malaria: Emerging technologies to study parasite-host interactions in the liver. Front Cell Infect Microbiol. 2020;10:606033.
Article
CAS
Google Scholar
Waite JL, Suh E, Lynch PA, Thomas MB. Exploring the lower thermal limits for development of the human malaria parasite. Plasmodium falciparum Biol Lett. 2019;15:20190275.
Watson J, Taylor WRJ, Menard D, Kheng S, White NJ. Modelling primaquine-induced haemolysis in G6PD deficiency. eLife. 2017;6:e23061.
Article
Google Scholar
White NJ. Why do some primate malarias relapse? Trends Parasitol. 2016;32:918–20.
Article
Google Scholar
WHO. Control and elimination of Plasmodium vivax malaria: a technical brief. World Health Organization; 2015.
Google Scholar
WHO. Global technical strategy for malaria 2016–2030 (WHO). 2015.
Google Scholar
WHO. World Malaria Report 2019. Geneva: WHO; 2019. [Google Scholar].
Google Scholar
WHO. WHO recommends groundbreaking malaria vaccine for children at risk. World Heal Organ 1. 2021. https://www.who.int/news/item/06-10-2021.
World Health Organization. World Malaria Report 2021: Reference Source. Geneva; World Health Organization; 2022.
Wilairatana P, Masangkay FR, Kotepui KU, De Jesus Milanez G, Kotepui M. Prevalence and risk of Plasmodium vivax infection among Duffy-negative individuals: a systematic review and meta-analysis. Sci Rep. 2022;12:1–13.
Article
Google Scholar
Zavala F. RTS,S: the first malaria vaccine. J Clin Invest. 2022;132(1):e156588. https://doi.org/10.1172/JCI156588.
Zhang R, Lee W-C, Lau Y-L, Albrecht L, Lopes SC, Costa FT, Suwanarusk R, Nosten F, Cooke BM, Rénia L. Rheopathologic consequence of Plasmodium vivax rosette formation. PLoS Negl Trop Dis. 2016;10:e0004912.
Article
Google Scholar
Zhang X, Wei H, Zhang Y, Zhao Y, Wang L, Hu Y, Nguitragool W, Sattabongkot J, Adams J, Cui L, et al. Genetic diversity of Plasmodium vivax reticulocyte binding protein 2b in global parasite populations. Parasit Vectors. 2022;15:205.
Article
CAS
Google Scholar
Zhong D, Koepfli C, Cui L, Yan G. Molecular approaches to determine the multiplicity of Plasmodium infections. Malar J. 2018;17:1–9.
Article
CAS
Google Scholar